CJC GTR 10 mg
CJC-1295 No DAC
A GHRH analogue, commonly called Modified GRF(1–29), for growth hormone signaling research.
This product is being prepared for release. Pricing and availability will be confirmed before ordering opens.
Every compound vial includes one 3 mL BAC Water and one compound / BAC pair holder.
Research Use Only (RUO)
For controlled laboratory and analytical research only. Not for human or veterinary use. Study findings describe experimental materials and models, not verified effects of this product.
What is CJC GTR?
CJC GTR supplies the no-DAC material commonly described as Modified GRF(1–29): a synthetic 29-amino-acid analogue of growth hormone-releasing hormone. It lacks the albumin-binding Drug Affinity Complex associated with long-acting CJC-1295.
Research interest includes GHRH-receptor activity and episodic hormone signaling. Results and half-life measurements from DAC-containing CJC-1295 studies should not be treated as direct evidence for the no-DAC material. No combination protocol or administration guidance is provided.
Specifications & reporting
- Compound
- CJC-1295 No DAC
- Selected vial amount
- 10 mg
- Format
- Lyophilized research material
- Batch / lot
- Not assigned
- COA
- Pending · no batch results posted
No purity, net-content or batch-testing result is claimed before a matching laboratory report is posted. Handling and stability depend on the material and experimental conditions; confirm lot-specific documentation before laboratory work.
Product labels
Black, silver and teal artwork with blank LOT / MFG / EXP fields. Packaging concept, 40 × 20 mm layout.
